The British drug-maker, AstraZeneca signed an exclusive deal with Beijing based Shenzhen Kangtai Biological Products Co., Ltd to manufacture a potential COVID-19 vaccine in mainland China.
source https://www.pharmatutor.org/pharma-news/2020/astrazeneca-signs-its-first-deal-with-kangtai-bio-to-supply-potential-covid-19-vaccine-in-china
No comments:
Post a Comment